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Abstract
Surgical interventions in the nasal cavity are accompanied by reactive phenomena in the postoperative period. On their
background the process of physiological regeneration is disorganized resulting in impaired physiological functions of the
nasal cavity.
The objective of the research was to study the recovery process of the main physiological functions of the nasal cavity in
patients with aspirin-intolerant polypous rhinosinusitis in the postoperative period.
Materials and methods. 80 patients with aspirin-intolerant polypous rhinosinusitis at the age of 24-57 years were operated
on.All the patients were divided into 2 groups: the control group included 30 patients; the main group comprised 50 patients.
Patients of the control group received nasal cavity cleaning, nasal mucosa anemisation, irrigation therapy since the first day
of the postoperative period.Patients of the main group received an herbal drug BNO-101 additionally. The effectiveness was
assessed on the 3rd, 7th and 10th days of treatment.
Results. The postoperative rehabilitation with the inclusion of botanical preparation BNO-101 provided a significant
improvement of nasal breathing, mucociliary transport rate and indicators of nasal peak flowmetry compared to the control
group. Despite subjective improvement of nasal breathing the indicators of the peak expiratory flow rate in the main group
were 34.2% lower than the norm while in the control group they were 54.7% lower than normal ones thereby justifying further
treatment.
Conclusions. The postoperative rehabilitation of patients with aspirin-intolerant polypous rhinosinusitis provided more rapid
improvement of the main functions of the nasal cavity compared to the control group.
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Problem statement and analysis of the
recent research
Nowadays, treatment of chronic polypous rhinosinusitis re-
mains to be difficult; therefore, it requires further improve-
ment [8]. The existing methods for treating polyposis can be
divided into two fundamentally opposite groups: conservative
and surgical ones. However, general approaches to treatment
of polypous rhinosinusitis associated with aspirin intolerance
are slightly different from those to treating polyposis of any
other etiology. Certainly, in the context of treating this form
of polyposis surgical removal of polyps eliminates the man-
ifestations but it does not eliminate the main cause of the
disease. It should not be considered as radical treatment since
aspirin-intolerant polypous rhinosinusitis is a metabolic dis-
ease caused by genetically determined defect of constitutive
cyclooxygenase being the key enzyme of the arachidonic acid
metabolism [2, 5]. In this situation, it would be appropriate
to cite a good quotation that when a doctor takes a scalpel,
he acknowledges his impotence. Nevertheless, polyps should
be removed as otherwise it will be difficult to restore nasal
breathing. Polypectomy is beneficial for patients relieving
nasal symptoms; however, only surgical treatment is ineffec-
tive and in most cases (75-80%) it results in the development
of recurrent polyposis and disease aggravation. Therefore,
most researchers are unanimous in their belief that the inte-
grated approach the main components of which are adequate
surgical interventions in combination with anti-relapse ther-
apy is the major and determining one [10, 12]. Functional
endonasal endoscopic surgery which allows performing early
anti-relapse therapy due to minimal surgical trauma is consid-
ered as an optimal operative treatment [1, 4].
Even modern minimally invasive endoscopic interventions
are accompanied by reactive phenomena in the postoperative
period. They can be conditionally grouped under the name of
“postoperative acute (traumatic) rhinosinusitis” which man-
ifests itself as the damage to the ciliated epithelium, edema
and exudation, changes in the rheological properties of nasal
mucus, degeneration and loss of cilia by ciliated cells, de-
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creased ciliary activity of the ciliated epithelium [1, 13]. On
the background of the aforementioned changes the process of
physiological regeneration of the mucous membrane in the
postoperative period is disorganized. The regenerative process
becomes pathological [6, 7].
On this basis, the main requirement for the management
of patients in the early postoperative period is to achieve the
elimination of the aforementioned reactive phenomena within
the shortest possible time as well as to orient the process of the
mucous membrane regeneration in the physiological direction.
We consider that the greatest attention should be paid to the
early postoperative period as its orientation in the physiologi-
cal direction is a guarantee of favorable course of the remote
postoperative period as well as a significant prerequisite for
the prevention of disease recurrences in the future [1, 7]. It
is of particular importance due to the noticeable progress of
endoscopic rhinosurgery the sparing and functional orienta-
tion of which often cause the need to stimulate the outflow of
pathological content from the zone of surgical intervention
in order to provide proper functioning of the natural sinus
drainage in the postoperative period.
In the early postoperative period, the use of medicines
which possess antiseptic, anti-edemic, anti-inflammatory, muco-
active action and create the possibilities for physiological pu-
rification of the injured mucosa, thereby, contributing to its
reparative regeneration is pathogenetically justified [7].
Since this refers to local changes in the zone of surgi-
cal intervention on the background of significant systemic
metabolic changes, in our opinion, pharmacotherapy should
be both local and systemic and the choice of therapeutic agents
should include the consideration of their effects on the func-
tion of the mucociliary apparatus. This combination should
find its level in the postoperative treatment of patients with
aspirin-intolerant polyposis. Modern combined standardized
herbal drug BNO-101 with proven effectiveness and safety
meets these requirements. It is used to treat acute and chronic
rhinosinusitis due to its versatile pharmacological action as it
includes medicinal herbs such as gentian root, primula flow-
ers, sorrel herb, elderberry flowers and verbena herb [9, 11,
14].
The objective of the research was to study the dynam-
ics of recovery of the nasal cavity functions in patients with
aspirin-intolerant polypous rhinosinusitis depending on the
postoperative rehabilitation scheme.
1. Materials and methods
The study included 80 patients at the age of 24-57 years (the
average age was 45.7±0.85) with chronic polypous rhinos-
inusitis associated with aspirin intolerance and indications
for surgical treatment who were treated in the ear, nose, and
throat (ENT) department of Ivano-Frankivsk Regional Clini-
cal Hospital during 2012-1015. There were 53 (66%) females
and 27 (34%) males which indicates the tendency to a greater
prevalence of this pathology among women.
Treatment of patients at the first stage included endoscopic
surgeries according to the methods of functional endoscopic
sinus surgery (FESS). In the presence of nasal comorbidity
(deviated nasal septum, enlarged nasal turbinates, synechia)
simultaneous surgery was performed in order to normalize
the main functions of the nasal cavity as well as to provide an
optimal endoscopic access to the elements of the ostiomeatal
complex. All the patients were divided into 2 groups: the
control group and the main group.
The control group (C) included 30 patients who received
standard therapy (nasal cavity cleaning, nasal mucosa anemi-
sation, irrigation therapy with salt water solutions) since the
first day of the postoperative period.
The main group (M) included 50 patients who received
an herbal drug BNO-101 according to the instructions (2 pills
or 50 drops three times a day) in addition to standard therapy
since the first day of the postoperative period.
Clinical evaluation of nasal breathing was performed ac-
cording to the dynamics of the patients’ complaints of nasal
congestion on the 1st, 3rd and 7th days of the postoperative
period. Subjective improvement of nasal breathing was regis-
tered in case when the expressiveness of the complaints did
not affect life quality.
The evaluation of nasal mucociliary clearance (NMC)
function was carried out using the saccharin test. A small
particle of saccharin approximately 1-1.5 mm in diameter
was placed on the inferior turbinate 1 cm behind its anterior
end. Patients were instructed to swallow every 60 seconds and
mention the moment they felt the sweet taste in the mouth.
The amount of time was measured using the stopwatch timer.
Time taken for sweat taste to be appreciated in the mouth was
considered as NMC time. Normally it is up to 20 minutes. The
evaluation of NMC function was carried out according to nasal
congestion on the 1st, 3rd and 7th days of the postoperative
period.
Instrumental evaluation of nasal breathing was carried out
using nasal peak flowmetry – the determination of the peak
expiratory flow rate (PEFR) on the 1st, 3rd and 7th days of
the postoperative period. The measurements were carried
out three times using a modified peak flowmeter Vitalograf
before and after nasal mucosa anemisation. The best indicator
was considered. Previously, there were determined normative
indicators in healthy volunteers. The average normative values
were 185-205 l/min for one nostril. When analyzing the data
the percentage deviation of the indices obtained in patients
from normative ones was calculated. The indicator was not
calculated when its value was less than 60 l/min, i.e. the
ultimate sensitivity of the device.
To assess the differences between groups one-factor dis-
persion analysis with subsequent use of the Tukey’s multiple
comparison test at a significance level of 0.05 was applied
[13].
2. Results and Discussion
When considering the patients’ complaints the greatest atten-
tion was paid to difficulty breathing through the nose or nasal
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Figure 1. Dynamics of subjective complaints
congestion. The patients’ complaints were evaluated in each
group separately. Fig. 1 illustrates their dynamics during
treatment.
Difficulty breathing through the nose within the first day
of the postoperative period was the most common symptom
being observed in almost all patients of the control (96.6%)
and the main groups (96%) (Fig. 1). Severe regression of
this clinical symptom was observed on the 3rd day of the
postoperative rehabilitation and its percentage in the control
group constituted 16.6% (5 patients) and in the main group
it was 6% (3 patients). The difference between groups was
statistically significant. On the 7th day, nasal breathing im-
proved significantly in most patients of the control group (29
persons – 96.56%) and all the patients of the main group (50
persons – 100%). There was observed a significant difference
in the results of treating patients of both groups in the context
of nasal breathing restoration on the 3rd and 7th days of the
postoperative period (Fig. 1).
Therefore, the normalization of the rheology of nasal mu-
cus as well as balanced anti-inflammatory and anti-edemic
action of herbal drug components resulted in more rapid nor-
malization of difficulty breathing through the nose in patients
of the main group compared to the control one.
When studying the state of mucociliary transport function
of the nasal mucosa on the 1st day of the postoperative period,
third-degree nasal mucociliary dysfunction was observed in
all the patients (Fig. 2).
In the control group, the mean value for saccharin per-
ception time was 62.3±0.03 min and in the main group it
was 63.1±0.09; the differences in the mean values for sac-
charin perception time between groups before treatment were
statistically insignificant (p>0.05). During treatment, grad-
ual reduction in saccharin perception time was noted. In the
control group on the 3rd day, the mean value for saccharin
perception time was 38.6±0.08 min (second-degree nasal mu-
cociliary dysfunction). 7 days after treatment onset, the value
for saccharin perception time in patients of this group was
21.6±0.09 min (first-degree nasal mucociliary dysfunction)
(Fig. 2).
The results of treating patients of the main group were
Figure 2. Dynamics of transport function restoration
better. On the 3rd day, patients developed second-degree nasal
mucociliary dysfunction (the saccharine test – 32.6±0.14
min). These indicators were better compared to those of the
control group; however, they indicated the tendency to the
improvement only as the difference between both groups was
statistically insignificant (p>0.05). On the 7th day, the indica-
tors of mucociliary clearance became normal (the saccharine
test – 18.8±0.10 min). The difference between the control
group and the main group was statistically significant, p<0.05.
Thus, the results of studying mucociliary clearance demon-
strated that treatment of patients of the main group resulted in
complete restoration of mucociliary transport function, while
in patients of the control group first-degree nasal mucociliary
dysfunction was observed. The results of treating patients of
the main group had a tendency to the improvement on the 3rd
day and were significantly better on the 7th day after treatment
(p<0.05).
Surgical treatment of aspirin-intolerant polyposis is ini-
tially a symptomatic method and the main goal of this inter-
vention is to relieve symptoms of nasal obstruction. However,
subjective sensation of improved nasal breathing should not be
considered as a criterion of treatment efficacy, since immedi-
ately after complete nasal obstruction even a slight subjective
relief of nasal breathing is positively perceived by patients.
Therefore, the dynamics of the postoperative period was ob-
jectified using nasal peak flowmetry. When analyzing the data
the percentage deviation of the indices obtained in patients
from normative values obtained in healthy individuals was
calculated (Fig. 3). In all the patients of both groups on the 1st
day of the postoperative period, the phenomena of complete
nasal obstructions were observed. Immediately after anemi-
sation of the mucous membrane of the nose, nasal patency
improved in all the patients. According to peak flowmetry
data however, the indicators of nasal patency reduced by one
half compared to normative values: 45.8% in the main group
and 45.6% in the control one.
On the 3rd day of the postoperative rehabilitation in pa-
tients of both groups subjective improvement of nasal breath-
ing was noted. When assessing the control group objectively
the PEFR indicators without anemisation were 23.3%. In
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Figure 3. Dynamics of nasal breathing restoration
according to nasal peak flowmetry data
patients who additionally received BNO-101 the PEFR indica-
tors without anemisation were better – 30.2% (the difference
between groups was statistically significant). After anemisa-
tion these indicators improved significantly in both groups –
62.4% in the main group and 62.2% in the control one (Fig.
3).
On the 7th day of the postoperative period alongside with
subjective improvement of nasal breathing the indicators of
nasal peak flowmetry without anemisation improved in both
groups as well. Its results were better in the main group
compared to the control one: 45.2% vs. 36.1%, respectively
(the difference between groups was statistically significant).
After anemisation, the indicators of both groups did not differ
both between themselves and from the results of previous
measurements: 65.8% in the main group and 65.4% in the
control one (Fig. 3).
On the 10th day of the postoperative period, the PEFR
indicators in the main group almost completely coincided
with those obtained after nasal mucosa anemisation: 65.8%
vs. 67.3%, however, they did not reach normative values. In
the control group, the PEFR indicators without anemisation
were worse compared to the main one: 45.3% vs. 65.8% (the
difference between groups was statistically significant). Simi-
larly, in the control group, the indicators without anemisation
were worse than those obtained after anemisation – 66.2%
(Fig. 3).
Thus, the dynamics of restoration of the PEFR in patients
who received BNO-101 was faster than in patients of the
control group. On the 10th day of the postoperative day the
indicators were equal to the required ones, i.e. those obtained
after careful anemisation of the nasal cavity. In the control
group, the dynamics restored slower and on the 10th day the
parameters did not reach the required values.
However, the required PEFR parameters in both groups
were significantly lower than normative values indicating the
necessity of further treatment of these patients.
Thus, the results of the research demonstrated that in
patients of the main group who received herbal drug BNO-
101 in addition to basic therapy in the postoperative period,
the dynamics of restoration of nasal breathing and mucociliary
transport function was the most intense. In our opinion, the
combination of systemic action of drug components with
topical preparations when treating patients of the main group
allowed us to effectively influence the key elements in the
pathogenesis of postoperative rhinosinusitis compared to local
treatment of patients of the control group.
3. Conclusions
1. The postoperative rehabilitation with the inclusion of
botanical drug BNO-101 when treating patients with
aspirin-intolerant polypous rhinosinusitis provides faster
improvement of nasal breathing according to the crite-
rion of subjective complaints.
2. Despite a significant subjective improvement of nasal
breathing the indicators of the peak expiratory flow rate
in the main group were 34.2% lower than the norm
while in the control group they were 54.7% lower than
normal ones thereby justifying further treatment and re-
flecting specific features of aspirin-intolerant polypous
rhinosinusitis etiopathogenesis.
3. The scheme of the early postoperative rehabilitation
provides faster normalization of mucociliary transport
function compared to the control group.
4. Prospects for further research
The study of the duration of relapse-free period in patients
with aspirin-intolerant polypous rhinosinusitis using the pro-
posed method of the early postoperative rehabilitation is promis-
ing.
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zin / Res Complement Med. 2006 Apr 19;13(2):78–87.
DOI: http://doi.org/10.1159/000091969
[10] Rimmer J, Fokkens W, Chong LY, Hopkins C. Sur-
gical versus medical interventions for chronic rhi-
nosinusitis with nasal polyps. In: Rimmer J, edi-
tor. Cochrane Database of Systematic Reviews. Chich-
ester, UK: John Wiley & Sons, Ltd; 2014. DOI:
http://doi.org/10.1002/14651858.CD006991.pub2
[11] Rossi A, Dehm F, Kiesselbach C, Haunschild J,
Sautebin L, Werz O. The novel Sinupret R© dry
extract exhibits anti-inflammatory effectiveness
in vivo. Fitoterapia. 2012 Jun;83(4):715–20. DOI:
http://doi.org/10.1016/j.fitote.2012.02.008
[12] Sharma R, Lakhani R, Rimmer J, Hopkins C. Surgical
interventions for chronic rhinosinusitis with nasal polyps.
In: Sharma R, editor. Cochrane Database of Systematic
Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2014.
DOI: http://doi.org/10.1002/14651858.CD006990.pub2
[13] Yan Y, Gordon WM, Wang D-Y. Nasal epithe-
lial repair and remodeling in physical injury, infec-
tion, and inflammatory diseases. Curr Opin Otolaryn-
gol Head Neck Surg. 2013 Jun;21(3):263–70. DOI:
http://doi.org/10.1097/MOO.0b013e32835f80a0
[14] Yaremchuk S, Zabolotny D, Vareniuk I, Makarchuk
N, Veselsky S. Sinupret R© oral drops protect against
respiratory epithelium atrophy in experimental acute
rhinitis. Clin Phytoscience. 2015 Dec 6;1(1):8 DOI:
http://doi.org/10.1097/MOO.0b013e32835f80a0
Received: 26 September 2016
Revised: 3 October 2016
Accepted: 3 October 2016
